Guardant Health, INC Form 4 insider transactions

Director Myrtle S. Potter reports acquisition and disposal of Guardant Health stock and derivative securities.

Director Steve Krognes reports acquisition and disposal of Guardant Health stock and derivative securities.

Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition and disposal of common stock and derivative securities.

Director Vijaya Gadde reported the acquisition and disposal of Guardant Health, Inc. stock and derivative securities.

Director Ian T. Clark reports transactions involving Guardant Health stock, including the vesting and disposal of restricted stock units and the grant of stock options.

Director Meghan Joyce reports the acquisition and disposition of Guardant Health (GH) common stock on June 4, 2024, including sales under a pre-arranged 10b5-1 plan.

John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Kumud Kalia, Chief Information Officer of Guardant Health, reports stock transactions including the vesting of restricted stock units and shares acquired under the Employee Stock Purchase Plan.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and related tax withholding.

Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.

Director Tariq Musa reported the acquisition and disposal of Guardant Health, Inc. common stock and restricted stock units on May 15, 2024.

Director Myrtle S. Potter reports a transaction involving Guardant Health, Inc. stock on May 15, 2024.

Chief Medical Officer of Guardant Health, Craig Eagle, reports the acquisition and disposal of common stock and restricted stock units on May 15, 2024.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent share transactions to cover tax obligations.

Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition of 66 shares of common stock through the vesting of restricted stock units on May 4, 2024.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., exercised stock options to acquire 200,000 shares of common stock at a price of $4.18 per share on May 3, 2024.

AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., exercised stock options to acquire 283,830 shares of common stock at a price of $4.18 per share.

Director Steve Krognes reports a transaction involving Guardant Health common stock on April 30, 2024.

Director Tariq Musa reports the vesting and conversion of restricted stock units into common stock.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Director Myrtle S. Potter reports the vesting of restricted stock units into common stock.

Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition and disposal of common stock and restricted stock units on April 4, 2024.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports the vesting and subsequent tax withholding related to restricted stock units.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting of restricted stock units and subsequent share sales to cover tax obligations.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.

Co-Chief Executive Officer of Guardant Health, AmirAli Talasaz, reports the vesting of restricted stock units and associated tax withholding.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.